NorthX Biologics utser branschveteraner till sin styrelse
June 14, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sverige, June 14, 2022 (GLOBE NEWSWIRE) -- Sverigebaserade NorthX Biologics ("NorthX"), som specialiserar sig på processutveckling och GMP-tillverkning av avancerade biologiska läkemedel,...
NorthX Biologics appoints industry veterans to its board of directors
June 14, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 14, 2022 (GLOBE NEWSWIRE) -- Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and GMP manufacture of advanced biological drugs, has announced the...
Leading medical device company to build Center for Excellence in Cellular Manufacturing in Greater Sacramento (Rancho Cordova)
March 28, 2022 13:42 ET
|
Greater Sacramento Economic Council
Sacramento (RANCHO CORDOVA), Calif., March 28, 2022 (GLOBE NEWSWIRE) -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), in partnership with the City of Rancho Cordova and the Greater Sacramento...
The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030, growing at an annualized rate of 18%, claims Roots Analysis
July 01, 2021 08:00 ET
|
Roots Analysis
London, July 01, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of offerings. Owing to the...
The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis
April 06, 2021 08:45 ET
|
Roots Analysis
London, April 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “CAR-T Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic...
The T-cell immunotherapy market is projected to grow at an annualized rate of 12.2%, claims Roots Analysis
February 11, 2021 12:03 ET
|
Roots Analysis
London, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition)-Distribution by Type of Therapy (CAR-T, TCR...
Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data
January 18, 2021 08:51 ET
|
Reports and Data
New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Increased investment in advanced technologies for treatment of genetic and chronic diseases is driving growth of the regenerative medicine market. Market...
Japanese Legislation Takes Effect for Expedited Approvals of Regenerative Medical Products
November 24, 2014 20:07 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) provided an update to the market on the Pharmaceuticals, Medical Devices and Other...